Pfizer vs. AbbVie: Is the Cheaper Pharma Stock Really the Better Investment?

Pfizer Inc. (NYSE:PFE) trades at a considerable discount to AbbVie Inc. (NYSE:ABBV), despite both companies reporting growth in important parts of their pharmaceutical portfolios. According to Yahoo Finance’s September 23, 2026 valuation snapshot, Pfizer trades at 9.67 times forward earnings, compared with AbbVie’s 16.39 times. That makes Pfizer cheaper on a forward P/E basis, but […]